Loading asset research
VolitionRX Limited Common Stock
VNRXNYSE · USD · StocksQuote as of · Exchange session not verified$0.2539
+1.56%
Today
VNRX
Loading 1D prices…
Market cap
$7.2M
Volume
856.7K
52w high
$14.8052w low
$0.23Company profile
VolitionRX Limited Common Stock
VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes. It also provides Nu.Q Cancer for predicting treatment response, monitoring treatment response and disease progression, and amending a patient's cancer treatment regimen; and Capture-PCR and Capture-Seq, which are isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection. VolitionRx Limited is headquartered in Henderson, Nevada.
Sector
Health Care
Industry
In Vitro & In Vivo Diagnostic Substances
Exchange
NYSE
Display currency
USD
Location
HENDERSON, NV, United States
Employees
57
Fiscal year end
1231
CIK
93314
Session & valuation
Open$0.25
Previous close$0.25
Day high$0.26
Day low$0.23
30-day avg. volume16.8M
Outstanding shares13.6M
Diluted EPS-$4.40
Latest annual period
P/E (trailing)-0.06
P/E (forward)-0.30
Price / book-0.10
Beta1.09
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2835
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| QCLSQ/C Technologies Inc. Common Stock | $7.2M | $0.00 | — | -$8.66 | -1.27% | Unrated |
| CDIOCardio Diagnostics Holdings Inc. Common stock | $5.8M | $14.8K | -43832.49% | -$3.71 | -0.52% | Hold |
| TRIBTrinity Biotech plc American Depositary Shares | $5.5M | $43.8M | -85.36% | -$53.10 | -0.86% | Unrated |
| BMRABiomerica Inc. Common Stock | $10.5M | $4.5M | -84.77% | -$1.30 | -5.75% | Unrated |
| VRAXVirax Biolabs Group Limited Ordinary Shares | $1.9M | $12.4K | -40439.10% | -$12.64 | -4.31% | Buy |